Duchenne or Becker muscular dystrophy
ICD-10 G71.01 is a billable code used to indicate a diagnosis of duchenne or becker muscular dystrophy.
Duchenne and Becker muscular dystrophies are genetic disorders characterized by progressive muscle degeneration and weakness due to mutations in the dystrophin gene located on the X chromosome. Duchenne muscular dystrophy (DMD) is the more severe form, typically presenting in early childhood, with symptoms such as delayed motor milestones, muscle weakness, and pseudohypertrophy of the calves. Becker muscular dystrophy (BMD) is a milder variant that usually manifests later in life and progresses more slowly. Both conditions primarily affect males, as they are X-linked recessive disorders. The absence or deficiency of dystrophin disrupts the integrity of muscle cell membranes, leading to muscle fiber damage and eventual replacement with fibrous and adipose tissue. Diagnosis is often confirmed through genetic testing, muscle biopsy, and clinical evaluation. Management focuses on maintaining mobility, preventing complications, and addressing associated cardiac and respiratory issues.
Detailed neurological assessments, genetic testing results, and treatment plans.
Diagnosis confirmation, management of muscle weakness, and monitoring of progression.
Ensure accurate documentation of muscle strength assessments and functional abilities.
Genetic testing results, family history, and counseling notes.
Genetic counseling for families, interpretation of genetic tests, and risk assessment.
Document the specific mutations identified and their implications for family members.
Used for confirming diagnosis of Duchenne or Becker muscular dystrophy.
Document the reason for testing and results.
Neurology and genetics must coordinate documentation.
Duchenne muscular dystrophy is characterized by an earlier onset and more severe symptoms, while Becker muscular dystrophy has a later onset and milder progression. Both are caused by mutations in the dystrophin gene.
